SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
436 Yeah, and the second is presumably the new program to enhance corticosteroids. scaram(o)uche-9/14/1997
435 Rick thanks. Just as an aside, Biogen did take a license from PDL for humanizaPseudo Biologist-9/14/1997
434 Max: OK. I see that you were focused on the Centocor versus Immunex issues rescaram(o)uche-9/14/1997
433 Thanks Vector. NFKappa is an intracellular factor involved in several signalliPseudo Biologist-9/14/1997
432 PB, its great to have both you and Rick on the thread. As the level of the scieVector1-9/14/1997
431 Uh? EAE? The mouse model for MS? OX40?? Cantab?? How did I bring all those uPseudo Biologist-9/13/1997
430 Exactly!! I was up to my eyeballs in OX40 and EAE a few years ago. Cantab wasscaram(o)uche-9/13/1997
429 Rick, thanks once again for your insights here. Interesting to point out the sPseudo Biologist-9/13/1997
428 V1: Nah, I haven't tried options for years. I've had remarkable luck scaram(o)uche-9/13/1997
427 Rick, thanks for the informative post. Do you play options often. I am a buy Vector1-9/13/1997
426 V1: Bear with you? It's a good question! The anti-CD40L that Biogen licescaram(o)uche-9/12/1997
425 Rick, like everyone else I am trying to predict the likelihood that the CD40L CVector1-9/12/1997
424 V1: Nice excerpt! Your question about monkeys is sorta open-ended. Got anythscaram(o)uche-9/12/1997
423 Harbor, the numbers are from Jeff Swarz's Sept 8 1997 report. I think he iVector1-9/11/1997
422 Vector1--Just wondering your source for estimated 98 and 99 eps. Zacks estimateHarbor-9/11/1997
421 Rick, How analogous is a Rhesus Monkey's immune system to a humans. I amVector1-9/11/1997
420 Are we going to see 30? CJCJ Mark-9/10/1997
419 Baird: I bought calls, hoping for excitement to develop after publication of tscaram(o)uche-9/5/1997
418 Rick, Thanks for your info on the anti-CD40L. It looks like BGEN is caught inCzechsinthemail-9/5/1997
417 This is why I don't like investing in top-tier biotechs. ;-) Comment.....scaram(o)uche-9/5/1997
416 from Briefing.com: BIOGEN INC. (BGEN) 35 7/16 -4 1/8. Issue has come under preCzechsinthemail-9/5/1997
415 Brad, just read Eric Hecht's report downgrading BGEN. Nothing particularlyVector1-9/5/1997
414 Anybody know the details of downgrade ? Hong-LeeHong-Lee Yu-9/5/1997
413 from Briefing.com: Biogen Inc. (BGEN) 37 3/8 -2 3/16: Merrill Lynch downgradesCzechsinthemail-9/5/1997
412 Annie: I usually try to disclose when I have a position in a company that I amscaram(o)uche-9/3/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News